Results 121 to 130 of about 6,519,345 (216)

Epilepsy, neuroinflammation and cannabidiol What do we know thus far? [PDF]

Front Pharmacol
Pesántez Ríos G, Perucca E, Striano P, Caraballo R, Pesántez Ríos X, Pascual-Pascual SI, Pesántez Cuesta G.   +6 more
europepmc   +1 more source

Gut microbiota-metabolite interactions in drug-induced liver injury: mechanisms, biomarkers, and therapeutic perspectives. [PDF]

Front Cell Infect Microbiol
Mao X, Hu X, Fang J.
europepmc   +1 more source

Light-Controlled Modulation of the Endocannabinoid System: Photoswitchable Ligands for Cannabinoid and TRPV1 Receptors. [PDF]

Int J Mol Sci
Corallo AA, Noli C, Brizzi A, Paolino M, Mugnaini C, Corelli F.   +5 more
europepmc   +1 more source

Gut Microbiota in the Regulation of Intestinal Drug Transporters: Molecular Mechanisms and Pharmacokinetic Implications. [PDF]

Int J Mol Sci
Rzeczycki P, Pęciak O, Plust M, Droździk M.   +3 more
europepmc   +1 more source

Unusually broad-spectrum small-molecule sensing using a single protein scaffold. [PDF]

Proc Natl Acad Sci U S A
Tian H, Beltrán J, George W, Lenert-Mondou C, Seder N, Davis ZI, Swift SD, Girke T, Whitehead TA, Wheeldon I, Cutler SR.   +10 more
europepmc   +1 more source

From Synaptic Plasticity to Neurotoxicity: Endocannabinoid Influence on Addiction and Neurodegeneration. [PDF]

Int J Mol Sci
Basavarajappa BS, Subbanna S.
europepmc   +1 more source

Progressive Destructive Hypothyroidism Associated with Sunitinib Therapy: A Three-Year Case Analysis. [PDF]

J Clin Med
Nosal M.
europepmc   +1 more source

The Therapeutic Potential of Dual NMR (NOP/MOP) Agonism in Pain Management. [PDF]

Pain Ther
Ciccocioppo R, Gudin J, Argoff CE, Offidani E, Hackworth J, Fam DS, Potenziano J.   +6 more
europepmc   +1 more source

Current State of the Neurotrophin-Based Pharmaceutics in the Treatment of Neurodegenerative Diseases and Neuroinflammation. [PDF]

Med Sci (Basel)
Fedotcheva TA, Shimanovsky NL.
europepmc   +1 more source